维普中文期刊产品整合服务
30篇 您的检索式:作者名="SILVERSTON PH"
    题名 作者 年代 出处 被引量
1稳定期双相情感障碍病人经丙戊酸钠治疗脑肌醇无显著意义的变化:在体磁共振频谱分析(英文)显示文摘目的 观察稳定期双向情感障碍病人使用丙戊酸钠后,定量测定脑代谢物在额叶和颞叶中的浓度,以确定与对照组相比是否存在差异。方法 对9名双相情感障碍的成年患者和11名健康志愿者进行检查,病人惟一服用的药物是丙戊酸钠(每日1000 mg),使用3 T磁共振机器和SMIS谱仪。应用PRESS序列(TE1 25 ms,TE2 25 ms;TR 3000 ms,128次平均)获得质子磁共振频谱数据。正方形体素的大小是2 cm×2 cm×2 cm,分别定位于额叶皮质、颞叶皮质和体外标准溶液。通过测算脑和标准溶液中代谢物的T1和T2值,获得准确的脑代谢物浓度。结果 病人组与健康组的谱线大致相似。与健康志愿者相比较,病人脑肌醇浓度没有显著意义的降低(额叶P=0.80,颞叶P=0.95,t检验)。同时,两组的胆碱、总肌酸和NAA也没有显著意义的差异。结论 在稳定期双向情感障碍病人,我们未观察到丙戊酸钠治疗后脑肌醇浓度有统计学意义的变化。为了获得确切的结论 ,需要在今后的研究中观察更多的病人。吴仁华 Silverstone PH 林艳 2010磁共振成像2010,1,3:2
2丙戊酸钠治疗双相情感障碍患者在体质子MR频谱分析显示文摘目的情绪稳定剂治疗双向情感障碍患者的细胞和分子基础尚未被充分阐明,文献中人体磁共振频谱的研究结果不一致,本研究旨在定量测定双向情感障碍患者服用丙戊酸钠后脑代谢物在额叶和颞叶中的浓度,确定与对照组之间是否存在差异。方法对9名双相情感障碍的成年患者(稳定期)和11名健康志愿者进行检查,应用PRESS序列获得质子磁共振频谱分析数据。正方形体素的大小为2×2×2 cm3,分别定位于额叶皮质、颞叶皮质和体外标准溶液。采用Marquardt方程拟合NAA、总肌酸、胆碱和肌醇的波峰,使用PERCH软件对各波峰面积进行测量,定量测定脑代谢物浓度。结果与健康志愿者相比,患者肌醇浓度并无统计学意义的降低(额叶P=0.79,颞叶P=0.94)。2组受试者的胆碱、总肌酸和NAA的差异亦无统计学意义。患者与健康志愿者的频谱相似。结论服用丙戊酸钠未明显改变稳定期双相情感障碍患者的脑内肌醇浓度。单磷酸肌醇、甘氨酸和大分子的信号可影响所测肌醇浓度的准确性。吴仁华 Silverstone PH 林艳 2007首都医科大学学报2007,28,6:2
3Venlafaxine in treatment-resistant major depression:a Canadian multienter,open-label trial显示文摘De Montigny C Silverstone PH Debonnel G 1999J Clin Psychopharmacol1999,19,5:1
4Current therapeutic strategies for anxious depressives 显示文摘Silverstone PH Studnitz E Buller R 2003Expert Rev Neurother2003,3,2:1
5Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study显示文摘Silverstone PH Donnell T Ulrich M 2002Hum Psychopharmacol2002,17,7:1
6Defining anxious depression:going beyond comorbidity显示文摘Silverstone PH von Studnitz E 2003Can J Psychiatry2003,48,10:1
7Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety显示文摘Silverstone PH Ravindran A 1999J Clin Psychiatry1999,60,:1
8Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder 显示文摘Silverstone PH Salinas E 2001J Clin Psychiatry2001,62,7:1
9Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study 显示文摘Silverstone PH Donnell T Ulrich M 2002Hum Psychopharmacol2002,17,7:1
10Bipolar disorder and myoinositol : a review of the magnetic resonance spectroscopy findings 显示文摘Silverstone PH McGrath BM Kim H 2005Bipolar Disorder2005,7,1:1
11A review of the possible relevance of inositol and the phosphatidyl inositol second messenger system (PI-cycle) to psychiatric disorders? Focus on magnetic resonance spectroscopy (MRS) studies 显示文摘Kim H McGrath BM Silverstone PH 2005Hum Psyehopharmacol2005,20,5:1
12Venlafax ine in treatment-resistant major depression: a Canadian multi center, open-label trial显示文摘de Montigny C Silverstone PH Debonnel G 1999J Clin Psychopharmacol1999,19,5:1
13Efficacy of venlafaxine extended re- lease in patients with major depressive disorder and comorbid gen- eralized anxiety disorder显示文摘Silverstone PH Salinas E 2001Journal of Clinical Psychiatry2001,62,7:1
14Once daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety显示文摘Silverstone PH Ravindran A 0,,:1
15Efficacy of venlafaxine extended release in patients with major depressive disorder and comobid generalized anxiety disorder显示文摘SILVERSTON PH SALINES E 2001J Clin Psychiatry2001,62,7:1
16Does ondansetron attenuate amphetamine-induced behaviour in human volunteers显示文摘Silverstone PH Johnson B Cowen PJ 1992Psycho- pharmacology (Berl)1992,107,1:1
17Venlafaxine in treatment-resistant major depression:a Canadian multicenter,open-label trial显示文摘De Montigny C Silverstone PH Hebonnel G 1999J Clin Psychopharmacol1999,19,5:1
18Once daily venlafaxine extended release(XR) compared with fluoxetine in outpa tients with depression and anxiety显示文摘Silverstone PH Ravindran A 1999J Clin Psychiatry1999,60,:1
19Chronic treatment with lithium,but not sodium valproate,increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients显示文摘Silverstone PH Wu RH O'Donnell T 0,,:1
20O daily venlafaxine extended release(XR) compared with fluoxetine in outpatients with depression and anxiety显示文摘Silverstone PH Ravindran A 1999J Clin Psychiatry1999,60,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费